Market revenue in 2023 | USD 4,478.2 million |
Market revenue in 2030 | USD 7,020.4 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 49.64% in 2023. Horizon Databook has segmented the North America interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The North America market for interventional cardiology devices is driven by factors such as the high prevalence of Cardiovascular Diseases (CVDs) and increasing adoption of minimally invasive procedures. The region has a well-established healthcare infrastructure and a high level of awareness about advanced medical treatments, contributing to market growth.
The interventional cardiology market is highly competitive in the region, with both global and local players contributing to market growth. Some key players in the region are Abbott, Boston Scientific, Medtronic, and St. Jude Medical (Abbott).
The market offers significant opportunities for growth through strategic collaborations and acquisitions. For instance, in September 2021, Boston Scientific acquired the global surgical business of Lumenis Ltd., a move aimed at expanding its portfolio of minimally invasive medical devices.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America interventional cardiology devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account